Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SPY vs GSK✓SelectedUSD · GSKSPY vs GSK performance historyLatest closeAs of-3.64%11/20
Stock and ETF performance explorer

SPY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+266.9%
GSK return
+97.4%
Excess return
+169.5%
Maximum drawdown
-33.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.6%-0.1%-3.5%-3.6%
7D-8.6%-5.3%-3.2%-7.1%
30D-10.8%-3.7%-7.1%-9.9%
3M-9.3%-7.3%-2.1%-7.5%
6M-6.5%-4.2%-2.2%-5.9%
YTD+1.9%+0.9%+1.1%+0.3%
1Y+6.9%+7.3%-0.4%+3.0%
3Y+57.5%+52.7%+4.7%+29.3%
5Y+57.3%+40.1%+17.2%+31.4%
All+266.9%+97.4%+169.5%+165.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling